AI_PREMie
A revolution in preeclampsia care
What is AI_PREMie?
Preeclampsia is a dangerous complication that can develop during pregnancy, affecting almost one in every 10 pregnancies. Preeclampsia is characterised by the development of high blood pressure and protein in the urine. However, warning signs are difficult to detect, meaning preeclampsia often goes undetected until complications become serious, often life threatening.
Professor Patricia Maguire of University College Dublin and her team have drawn upon cutting-edge biomedical, clinical and machine-learning research to develop a prototype risk stratification tool, AI_PREMie, that identifies women with preeclampsia and how they will progress. AI_PREMie has been rated excellent in the UNESCO Global Top 100 AI projects addressing the 17 UN sustainable goals.
Addressing a global health challenge
1
%
Pregnancies
Preeclampsia affects 1 in 10 pregnancies.
1
Mothers
Preeclampsia claims the lives of 50,000 mothers annually.
1
Babies
Preeclampsia claims the lives of 500,000 babies annually.
The impact of AI_PREMie will be a game changer in tackling preeclampsia. As a clinician, I cannot wait to use it as part of our care.
Professor Mary Higgins
Consultant Obstetrician and Gynaecologist, National Maternity Hospital, Dublin
Meet the AI_PREMie team
The AI_PREMie project is led by Professor Patricia Maguire from the UCD School of Biomolecular and Biomedical Science.
Prof Maguire leads a rapidly expanding transdisciplinary team of healthcare and AI experts as well as industry partners and business leaders.
Also from the UCD ConwaySPHERE research group, the AI_PREMie team includes consultant haematologist and Full Clinical Professor Fionnuala Ní Áinle from UCD School of Medicine, and consultant obstetrician and gynaecologist Professor Mary Higgins from National Maternity Hospital.
AI_PREMie was awarded €500,000 by SFI in recognition of the potential impact of their AI-powered risk stratification platform for preeclampsia.
